Federico Stella, MD^1*, Vincenzo Marasco, MD^2*, Giorgia Virginia Levati, MD^3*, Cecilia Vismara, MD^4*, Anna Guidetti, MD⁵, Annalisa Chiappella, MD⁶, Giulia Perrone, MD^7*, Cristina Tecchio, MD^8*, Nicola Mordini, MD^9*, Martina Pennisi, MD^10*, Giorgia Ferrara^11*, Giorgia Gobbi^12*, Lucia Saracino^12*, Cristiana Carniti^13* and Paolo Corradini, MD¹⁴

¹Università degli Studi di Milano, Milan, AL, Italy
²Hematology and Bone Marrow Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy
³Istituto Nazionale dei Tumori di Milano, Milano, ITA
⁴Università degli Studi di Milano, Milan, Italy
⁵Università di Milano, Milano, Italy
⁶Division of Hematology & Stem Cell Transplant, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Milano, Italy
⁷IRCCS Istituto Nazionale dei Tumori, Milan, Italy
⁸Department of Medicine, Hematology and Bone Marrow Transplant Unit, Verona University Hospital, Verona, Italy
⁹Santa Croce e Carle, UO Ematologia, Cuneo, Italy
¹⁰Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
¹¹Istituto Nazionale dei Tumori Milano, Milan, Italy
¹²Istituto Nazionale dei Tumori di Milano, Milan, Italy
¹³Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
¹⁴Università degli Studi di Milano and Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCSS) Istituto Nazionale dei Tumori, Milan, Italy

Narendranath Epperla, MD, MS¹, Qiuhong Zhao, MS^2*, Lauren Shea, MD^3*, Reem Karmali, MD, MSc⁴, Pallawi Torka, MD⁵, Timothy Seijung Oh, MD^6*, Andrea Anampa-Guzman, MD^5*, Ximena Jordan Bruno, MD⁷, Elvira Umyarova, MD⁷, Kathryn Lindsey, MD^8*, Irl Brian Greenwell, MD⁸, Sayan Mullick Chowdhury, DO, PhD^9*, Yazeed Sawalha, MD¹⁰, Beth Christian¹¹, Natalie S. Grover, MD¹², Nancy L. Bartlett, MD¹³ and Adam J. Olszewski, MD¹⁴

¹The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
²Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
³Washington University, St. Louis, MO
⁴Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL
⁵Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁶Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
⁷University of Vermont, Burlington, VT
⁸Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
⁹Ohio State University Medical Center, Columbus, OH
¹⁰Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH
¹¹The Ohio State University Comprehensive Cancer Center, Columbus, OH
¹²Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
¹³Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
¹⁴Division of Hematology/Oncology, Brown University, Providence, RI

Hira S Mian, MD, MSc¹, Tanya Wildes, MD, MSc², Ravi Vij, MD, MBBS^3,4, Ajay Major, MD, MBA⁵ and Mark A Fiala, PhD^6*

¹Department of Oncology, McMaster University, Hamilton, ON, Canada
²University of Nebraska Medical Center, Omaha, NE
³Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
⁴Division of Medical Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO
⁵University of Colorado School of Medicine, Denver, CO
⁶Department of Medicine, Division of Hematology & Oncology, Washington University School of Medicine, St. Louis, MO

Gabriell Erisnor, BS^1*, Jiona Mills, BSPH^2*, Paul Mihas, MA^3*, Lauren Bates, MA^4*, Mykela Moore, BA^2*, Tanya M. Wildes, MD^5*, Leah Adams, BS^6*, Hyman B Muss, MD^7,8 and Shakira J. Grant, MBBS^7,9

¹School of Medicine, City University of New York, New York, NY
²Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC
³Odum Institute for Research in Social Sciences, The University of North Carolina at Chapel Hill, Chapel Hill, NC
⁴Department of Allied Health Sciences, The University of North Carolina at Chapel Hill, Chapel Hill, NC
⁵Division of Oncology & Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE
⁶School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC
⁷Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC
⁸Department of Medicine, Division of Medical Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, NC
⁹Department of Medicine, Division of Hematology, The University of North Carolina at Chapel Hill, Chapel Hill, NC

Arleigh McCurdy, MD, BSc¹, Hsien Seow, PhD^2*, Gregory R Pond, PhD, PStat^3*, Anastasia Gayowsky, MSc^4*, Rajshekhar Chakraborty, MD⁵, Alissa Visram, MD⁶, Rayan Kaedbey, MD⁷, Anita D'Souza, MD, MS⁸, Ghulam Rehman Mohyuddin, MD⁹, Rafael Fonseca¹⁰ and Hira S Mian, MD, MSc³

¹Department of Medicine, Division of Hematology, The Ottawa Hospital, Ottawa, ON, Canada
²Oncology, McMaster University, Hamilton, ON, Canada
³Department of Oncology, McMaster University, Hamilton, ON, Canada
⁴ICES McMaster, Hamilton, ON, Canada
⁵Department of Medicine, Columbia University Irving Medical Center, Thornwood, NY
⁶Department of Medicine, University of Ottawa, The Ottawa Hospital Research Institute, Ottawa, ON, Canada
⁷Jewish General Hospital, McGill University, Montreal, Montreal, QC, CAN
⁸Center for International Blood and Marrow Transplant Research, Department of Medicine, The Medical College of Wisconsin Inc., Milwaukee, WI
⁹Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT
¹⁰Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ

Patrick Blaney, MS^1,2*, Eileen M Boyle, MD, MSc¹, Kylee H Maclachlan, MBBCh, PhD³, Louis S. Williams, MD⁴, Dylan Gagler, MS^1,2*, Parvathi Sudha, MS^5*, Alexandra M Poos, PhD^6*, Yubao Wang, PhD^1*, Hussein Ghamlouch, PhD^1*, Avital Tenenbaum^1*, Ariel Siegel, MD^1*, Xiaoyi Chen, MD, PhD¹, Gaurav Varma, MD, MSPH¹, David Kaminetzsky, MD^1*, Marc Braunstein, MD, PhD¹, David Coffey, MD⁷, Benjamin Diamond, MD⁷, Bachisio Ziccheddu, PhD^7*, Dickran Kazandjian, MD⁷, Urvi A Shah, MD³, Elizabeth E. Brown, PhD, MPH⁸, Elisabet E. Manasanch, M.D.⁹, Alexander M Lesokhin, MD³, Niels Weinhold, PhD^6*, Brian A. Walker, PhD⁵, Saad Usmani, MD³, Ola Landgren, MD¹⁰, Faith E Davies, MD¹, Francesco Maura, MD¹¹ and Gareth J. Morgan, MD¹

¹Myeloma Research Program, Perlmutter Cancer Center, NYU Langone Health, New York, NY
²Applied Bioinformatics Laboratories, NYU Langone Health, New York, NY
³Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Hematology and Medical Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
⁵Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology Oncology, Indiana University, Indianapolis, IN
⁶Multiple Myeloma Research Group, Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
⁷Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
⁸University of Alabama at Birmingham, O’Neal Comprehensive Cancer Center, Birmingham, AL
⁹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Myeloma Division, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
¹¹Myeloma Program, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, PALMETTO BAY, FL